Spondyloarthritis & psoriatic arthritis
Vitamin D in psoriatic arthritis – A systematic review and meta-analysis
Authors' conclusion
In conclusion, PsA patients have lower vitamin D levels than the general population.
Study context
- Population
- Studies assessing 25(OH)D3 levels in PsA with healthy or psoriasis (Pso) control groups4 + 5 studies
- Comparison
- PsA vs healthy controls and vs Pso patients
- Healthy controlsn = 287reference
- Pson = 391reference
- Outcome
- Vitamin D (25(OH)D3) levels
Methodological detailsrandom effects model, inverse variance weighting, Included studies had moderate to low risk of bias
- Random effects model
- Inverse variance weighting
- Included studies had moderate to low risk of bias
Pooled result
As reported in the abstract
Vitamin D levels
MD (95 % CI)P value
PsA vs Healthy controls4 studies; 264 PsAvs 287 healthy controls
−6.42(−8.31 to −4.53)
P < 0.01PsA vs Pso5 studies; 225 PsAvs 391 Pso
2.37(0.97–3.78)
P < 0.01Original publication
Vitamin D in psoriatic arthritis – A systematic review and meta-analysis. Semin Arthritis Rheum. Published 1 April 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →